Detail page

Knowledge Web

Person

Cezmi A. Akdis (1961-)

Arzt

Name	Cezmi A. Akdis
Time	1961- (Date of birth and death)
Place	Schweiz
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession)
Variant	Cezmi Akdis
Related	Schweizerisches Institut für Allergie- und Asthmaforschung (Direktor) Christine Kühne-Center for Allergy Research and Education Immunologie (Thema)
Further information	Seit 2014: Professor für Experimentelle Allergologie und Immunologie an der Universität Zürich
Record type	Person
GND-Identifier	1089302452
Record ID	1089302452
Involved in show all Immune impacts of fire smoke exposure Type 2 immunity in allergic diseases Neue Nomenklatur allergischer Erkrankungen nach EAACI-Standard : Teil 4: Nomenklatur von Allergien vom Typ V-VII Aerosol measurements and decadal changes: the role of climatic changes and how it reflects in respiratory allergies and asthma Environmental exposures influence multigenerational epigenetic transmission Lifestyle Changes and Industrialization in the Development of Allergic Diseases Neue Nomenklatur allergischer Erkrankungen nach EAACI-Standard : Teil 1: Grundlagen und Nomenklatur von Soforttyp-Allergien (Typ 1) - Executive Summary eines EAACI-Positionspapiers Climate change and allergic diseases: a scoping review Climate crisis paralysis: accelerating global action for health resilience in a changing world [Editorial] Navigating the evolving landscape of atopic dermatitis: challenges and future opportunities: the 4th Davos Declaration The epithelial barrier theory and its associated diseases The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma The impact of indoor pollution on asthma‐related outcomes: a systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: a systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma Ein großer Verlust für die gesamte Allergologie Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood EAACI Guidelines on environmental science in allergic diseases and asthma – leveraging artificial intelligence and machine learning to develop a causality model in exposomics Is exposure to pollen a risk factor for moderate and severe asthma exacerbations? Obituary: Jörg Kleine‐Tebbe Spatial and single-cell transcriptomics provide insights into the complex inflammatory cell network in atopic dermatitis [Abstract] Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis Human and planetary health on fire Epithelial barrier hypothesis and the development of allergic and autoimmune diseases Epithelial barrier hypothesis and the development of allergic and autoimmune diseases Alpine altitude climate treatment for severe and uncontrolled asthma: an EAACI position paper Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract] Climate change and global health: a call to more research and more action An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19 Advances and highlights in biomarkers of allergic diseases Dysregulation of the epithelial barrier by environmental and other exogenous factors Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c Enhancing Data Reliability in TOMAHAQ for Large‐Scale Protein Quantification Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma Unraveling the complexity of atopic dermatitis: the CK‐CARE approach toward precision medicine Rhinovirus species and tonsillar immune responses Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care Immunological methods for diagnosis and monitoring of IgE‐mediated allergy caused by industrial sensitizing agents (IMExAllergy) Precision/Personalized Medicine in Allergic Diseases and Asthma Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis Microbiome and asthma Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis The role of environmental factors in allergy: a critical reappraisal Precision Medicine in Allergic Disorders Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? Allergen immunotherapy for allergic asthma: protocol for a systematic review Cellular and molecular immunologic mechanisms in patients with atopic dermatitis Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens Rhinovirus infection has allergen-specific tolerance-breaking effects on PBMCs of healthy individuals Soluble mediators derived from bronchial epithelium are able to drive Th2 differentiation in the context of rhinovirus infection The biodiversity hypothesis and allergic disease: world allergy organization position statement Atopic eczema and allergies: practical relevance for diagnostic work-up Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema Mechanisms of allergen-specific immunotherapy Fighting allergies beyond symptoms: The European Declaration on Immunotherapy Role of Treg in immune regulation of allergic diseases Nature of Regulatory T Cells in the Context of Allergic Disease Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Cezmi A. Akdis (1961-)

Immune impacts of fire smoke exposure

Type 2 immunity in allergic diseases

Neue Nomenklatur allergischer Erkrankungen nach EAACI-Standard : Teil 4: Nomenklatur von Allergien vom Typ V-VII

Aerosol measurements and decadal changes: the role of climatic changes and how it reflects in respiratory allergies and asthma

Environmental exposures influence multigenerational epigenetic transmission

Lifestyle Changes and Industrialization in the Development of Allergic Diseases

Neue Nomenklatur allergischer Erkrankungen nach EAACI-Standard : Teil 1: Grundlagen und Nomenklatur von Soforttyp-Allergien (Typ 1) - Executive Summary eines EAACI-Positionspapiers

Climate change and allergic diseases: a scoping review

Climate crisis paralysis: accelerating global action for health resilience in a changing world [Editorial]

Navigating the evolving landscape of atopic dermatitis: challenges and future opportunities: the 4th Davos Declaration

The epithelial barrier theory and its associated diseases

The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma

The impact of indoor pollution on asthma‐related outcomes: a systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma

The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: a systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma

Ein großer Verlust für die gesamte Allergologie

Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood

EAACI Guidelines on environmental science in allergic diseases and asthma – leveraging artificial intelligence and machine learning to develop a causality model in exposomics

Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?

Obituary: Jörg Kleine‐Tebbe

Spatial and single-cell transcriptomics provide insights into the complex inflammatory cell network in atopic dermatitis [Abstract]

Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis

Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis

Human and planetary health on fire

Epithelial barrier hypothesis and the development of allergic and autoimmune diseases

Epithelial barrier hypothesis and the development of allergic and autoimmune diseases

Alpine altitude climate treatment for severe and uncontrolled asthma: an EAACI position paper

Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract]

Climate change and global health: a call to more research and more action

An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism

Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19

Advances and highlights in biomarkers of allergic diseases

Dysregulation of the epithelial barrier by environmental and other exogenous factors

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c

Enhancing Data Reliability in TOMAHAQ for Large‐Scale Protein Quantification

Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma

Unraveling the complexity of atopic dermatitis: the CK‐CARE approach toward precision medicine

Rhinovirus species and tonsillar immune responses

Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care

Immunological methods for diagnosis and monitoring of IgE‐mediated allergy caused by industrial sensitizing agents (IMExAllergy)

Precision/Personalized Medicine in Allergic Diseases and Asthma

Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis

Microbiome and asthma

Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis

The role of environmental factors in allergy: a critical reappraisal

Precision Medicine in Allergic Disorders

Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go?

Allergen immunotherapy for allergic asthma: protocol for a systematic review

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens

Rhinovirus infection has allergen-specific tolerance-breaking effects on PBMCs of healthy individuals

Soluble mediators derived from bronchial epithelium are able to drive Th2 differentiation in the context of rhinovirus infection

The biodiversity hypothesis and allergic disease: world allergy organization position statement

Atopic eczema and allergies: practical relevance for diagnostic work-up

Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema

Mechanisms of allergen-specific immunotherapy

Fighting allergies beyond symptoms: The European Declaration on Immunotherapy

Role of Treg in immune regulation of allergic diseases

Nature of Regulatory T Cells in the Context of Allergic Disease

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants